| GC11400-5mg |
|
120287-85-6 |
|
0 |
C70H92ClN17O14 |
|
|
|
| GC11399-25mg |
|
1245526-82-2 |
Glucocorticoid receptor agonist
|
0 |
C20H20F4N2O2 |
|
|
|
| GC11399-10mg |
|
1245526-82-2 |
Glucocorticoid receptor agonist
|
0 |
C20H20F4N2O2 |
|
|
|
| GC11399-5mg |
|
1245526-82-2 |
Glucocorticoid receptor agonist
|
0 |
C20H20F4N2O2 |
|
|
|
| GC11397-50mg |
|
544697-47-4 |
|
0 |
C15H15N3O6 |
|
|
|
| GC11397-10mg |
|
544697-47-4 |
|
0 |
C15H15N3O6 |
|
|
|
| GC11396-10mM (in 1mL DMSO) |
|
345627-80-7 |
|
0 |
C17H24N4O2S2 |
|
|
|
| GC11396-100mg |
|
345627-80-7 |
|
0 |
C17H24N4O2S2 |
|
|
|
| GC11396-25mg |
|
345627-80-7 |
|
0 |
C17H24N4O2S2 |
|
|
|
| GC11396-5mg |
|
345627-80-7 |
|
0 |
C17H24N4O2S2 |
|
|
|
| GC11395-50mg |
|
1263094-00-3 |
7-Chlorokynurenic acid sodium salt
|
0 |
C10H5ClNNaO3 |
|
|
|
| GC11395-10mg |
|
1263094-00-3 |
7-Chlorokynurenic acid sodium salt
|
0 |
C10H5ClNNaO3 |
|
|
|
| GC11394-5g |
|
7365-45-9 |
|
0 |
C8H18N2O4S |
|
|
|
| GC11393-5mg |
|
108375-77-5 |
|
0 |
C43H68O12 |
|
|
|
| GC11393-1mg |
|
108375-77-5 |
|
0 |
C43H68O12 |
|
|
|
| GC11391-10mM (in 1mL DMSO) |
|
857402-63-2 |
IPI-504 (Retaspimycin hydrochloride)
|
0 |
C31H46ClN3O8 |
|
|
|
| GC11391-100mg |
|
857402-63-2 |
IPI-504 (Retaspimycin hydrochloride)
|
0 |
C31H46ClN3O8 |
|
|
|
| GC11391-50mg |
|
857402-63-2 |
IPI-504 (Retaspimycin hydrochloride)
|
0 |
C31H46ClN3O8 |
|
|
|
| GC11391-10mg |
|
857402-63-2 |
IPI-504 (Retaspimycin hydrochloride)
|
0 |
C31H46ClN3O8 |
|
|
|
| GC11391-5mg |
|
857402-63-2 |
IPI-504 (Retaspimycin hydrochloride)
|
0 |
C31H46ClN3O8 |
|
|
|
